As an experienced intellectual property attorney with a strong background in complex litigation and a deep technical foundation—particularly in the biopharma and technology sectors—Lexi brings a results-driven, strategic approach to handling all facets of intellectual property disputes. She has represented clients in high-stakes matters involving patents, trade secrets, and licensing, both at Big Law and boutique IP firms. Her litigation experience spans the full case lifecycle—from pre-suit investigation and strategy through discovery, motion practice, and trial preparation.
As Lexi expands her practice to include broader IP counseling and portfolio management, she leverages her litigation insight to help clients proactively protect and enforce their rights across all areas of IP. She routinely advises on infringement risk, enforcement strategy, ownership and validity issues, and brand protection—helping businesses and individuals safeguard and maximize the value of their intellectual property.
With a practice grounded in precision, advocacy, and a comprehensive understanding of both legal and technical frameworks, Lexi is committed to guiding clients across industries through the evolving IP landscape with confidence and clarity.
GSC Logistics, Inc. v. Amazon.Com Services LLC
Representing the defendant in a dispute regarding repudiation of a transloading services contract.
Juanita's Foods v. Dominguez Family Enterprises, Inc.
Representing the defendant in an arbitration action concerning enforcement of a settlement agreement between Mexican food product manufacturers.
Stangenes Industries, Inc. v. Scandinova Systems AB
Representing the plaintiff in a trade secret misappropriation action related to pulse transformers.
MHCS v. Boardwalk Investments Yountville, LLC
Representing the defendant in a trademark infringement action concerning certain marks related to VEUVE CLICQUOT brand Champagne.
Genentech, Inc., et al. v. Sandoz Inc., et al., 23-04085 (D.N.J.)*
Represented the plaintiffs in an infringement suit regarding the at-risk launch of pirfenidone, marketed by Genentech as Esbriet®.
Admitted to Practice
- District of Columbia
- North Carolina
- U.S. Court of Appeals, Federal Circuit
Education
- J.D., North Carolina Central University School of Law, 2018, magna cum laude
- Black Entertainment and Sports Lawyers Association
- Sidney B. Williams Jr. Intellectual Property Law Scholar
- Editor-in-Chief, Biotechnology and Pharmaceutical Law Review, 2017-2018
- President, Intellectual Property Society, 2016-2018
- B.A., Biology, Tuskegee University, 2015, summa cum laude
Background
- Managing Associate, Orrick, Herrington & Sutcliffe LLP, Washington, D.C., 2023-2025
- Associate, Crowell & Moring, Washington, D.C., 2021-2023
- Associate, Brinks, Gilson & Lione, Research Triangle Park, N.C., 2018-2021